Thrivent Financial for Lutherans’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-42,435
Closed -$285K 2429
2023
Q2
$285K Sell
42,435
-2,082
-5% -$14K ﹤0.01% 2335
2023
Q1
$393K Sell
44,517
-248,226
-85% -$2.19M ﹤0.01% 2217
2022
Q4
$2.24M Buy
292,743
+4,196
+1% +$32K 0.01% 1183
2022
Q3
$2.05M Buy
288,547
+13,787
+5% +$98.1K 0.01% 1200
2022
Q2
$2.22M Sell
274,760
-18,196
-6% -$147K 0.01% 1174
2022
Q1
$4.07M Sell
292,956
-294,814
-50% -$4.09M 0.01% 962
2021
Q4
$16.5M Buy
587,770
+24,508
+4% +$688K 0.03% 524
2021
Q3
$19.1M Buy
563,262
+14,086
+3% +$479K 0.04% 476
2021
Q2
$22.4M Buy
549,176
+111,051
+25% +$4.54M 0.05% 426
2021
Q1
$17.6M Buy
+438,125
New +$17.6M 0.04% 483
2020
Q4
Hold
0
2153